Solutions to make life better

In August 2017, Renew acquired the Intelesens business, and its portfolio of intelligent, wearable, non-invasive, vital signs monitoring devices for the hospital and home patient monitoring markets including the Zensor™ device and Zensor™ + Analysis Software.

 

In 2020, The LifeSignals Group acquired the connected health assets from Renew including the Zensor™ device and Zensor™ + Analysis Software. With its wide-ranging assets, LifeSignals plans to accelerate the global adaptation of clinical-grade wireless biosensors and software by working with healthcare service providers, thereby improving healthcare delivery to currently underserved populations.

 

For more information on LifeSignals visit www.lifesignals.com